These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9565563)

  • 1. pH-induced conformational transitions of the propeptide of human cathepsin L. A role for a molten globule state in zymogen activation.
    Jerala R; Zerovnik E; Kidric J; Turk V
    J Biol Chem; 1998 May; 273(19):11498-504. PubMed ID: 9565563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidic pH as a physiological regulator of human cathepsin L activity.
    Turk B; Dolenc I; Lenarcic B; Krizaj I; Turk V; Bieth JG; Björk I
    Eur J Biochem; 1999 Feb; 259(3):926-32. PubMed ID: 10092883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The slow-binding inhibition of cathepsin K by its propeptide.
    Billington CJ; Mason P; Magny MC; Mort JS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):924-9. PubMed ID: 11027570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid-induced molten globule state of a fully active mutant of human interleukin-6.
    De Filippis V; de Laureto PP; Toniutti N; Fontana A
    Biochemistry; 1996 Sep; 35(35):11503-11. PubMed ID: 8784206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the Fasciola hepatica newly excysted juvenile cathepsin L3 (FhCL3) by its propeptide: a proposed 'clamp-like' mechanism of binding and inhibition.
    Pritsch IC; Tikhonova IG; Jewhurst HL; Drysdale O; Cwiklinski K; Molento MB; Dalton JP; Verissimo CM
    BMC Mol Cell Biol; 2020 Dec; 21(1):90. PubMed ID: 33287692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propetide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells.
    Collins PR; Stack CM; O'Neill SM; Doyle S; Ryan T; Brennan GP; Mousley A; Stewart M; Maule AG; Dalton JP; Donnelly S
    J Biol Chem; 2004 Apr; 279(17):17038-46. PubMed ID: 14754899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
    Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
    Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of cathepsin S by its propeptide--specificity and mechanism of action.
    Maubach G; Schilling K; Rommerskirch W; Wenz I; Schultz JE; Weber E; Wiederanders B
    Eur J Biochem; 1997 Dec; 250(3):745-50. PubMed ID: 9461297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrophobic core variant ubiquitin forms a molten globule conformation at acidic pH.
    Park SH
    J Biochem Mol Biol; 2004 Nov; 37(6):676-83. PubMed ID: 15607026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of propeptide-enzyme interaction in cathepsin L-like cysteine proteases.
    Schilling K; Körner A; Sehmisch S; Kreusch A; Kleint R; Benedix Y; Schlabrakowski A; Wiederanders B
    Biol Chem; 2009 Feb; 390(2):167-74. PubMed ID: 19040358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha1/2 helical backbone of the prodomains defines the intrinsic inhibitory specificity in the cathepsin L-like cysteine protease subfamily.
    Guo YL; Kurz U; Schultz JE; Lim CC; Wiederanders B; Schilling K
    FEBS Lett; 2000 Mar; 469(2-3):203-7. PubMed ID: 10713271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation processing of cathepsin H impairs recognition by its propeptide.
    Horn M; Dolecková-Maresová L; Rulísek L; Mása M; Vasiljeva O; Turk B; Gan-Erdene T; Baudys M; Mares M
    Biol Chem; 2005 Sep; 386(9):941-7. PubMed ID: 16164419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-crystallin binds to the aggregation-prone molten-globule state of alkaline protease: implications for preventing irreversible thermal denaturation.
    Tanksale A; Ghatge M; Deshpande V
    Protein Sci; 2002 Jul; 11(7):1720-8. PubMed ID: 12070325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
    Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA
    Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of phospholipase A2 from functional perspective. 2. Characterization of a molten globule-like state induced by site-specific mutagenesis.
    Yuan C; Byeon IJ; Poi MJ; Tsai MD
    Biochemistry; 1999 Mar; 38(10):2919-29. PubMed ID: 10074344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol-induced conformational transitions in ervatamin C. An alpha-helix to beta-sheet switchover.
    Sundd M; Kundu S; Jagannadham MV
    J Protein Chem; 2000 Apr; 19(3):169-76. PubMed ID: 10981808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of Ala205 on the specificity of cathepsin L produced by dextran sulfate assisted activation of the recombinant proenzyme.
    Barlic-Maganja D; Dolinar M; Turk V
    Biol Chem; 1998 Dec; 379(12):1449-52. PubMed ID: 9894813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface activation of pro-cathepsin L.
    Mason RW; Massey SD
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1659-66. PubMed ID: 1482371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin X binds to cell surface heparan sulfate proteoglycans.
    Nascimento FD; Rizzi CC; Nantes IL; Stefe I; Turk B; Carmona AK; Nader HB; Juliano L; Tersariol IL
    Arch Biochem Biophys; 2005 Apr; 436(2):323-32. PubMed ID: 15797245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein inhibitors form complexes with procathepsin L and augment cleavage of the propeptide.
    Majerle A; Jerala R
    Arch Biochem Biophys; 2003 Sep; 417(1):53-8. PubMed ID: 12921779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.